Robert B. Stein

8.1k total citations · 3 hit papers
96 papers, 6.7k citations indexed

About

Robert B. Stein is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Robert B. Stein has authored 96 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 25 papers in Oncology and 22 papers in Genetics. Recurrent topics in Robert B. Stein's work include Microscopic Colitis (12 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Inflammatory Bowel Disease (11 papers). Robert B. Stein is often cited by papers focused on Microscopic Colitis (12 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Inflammatory Bowel Disease (11 papers). Robert B. Stein collaborates with scholars based in United States, Japan and Germany. Robert B. Stein's co-authors include Richard A. Heyman, Gregor Eichele, Ronald M. Evans, Jacqueline A. Dyck, David J. Mangelsdorf, Christina Thaller, Stephen B. Hanauer, W. Robert Bishop, J E Niedel and Robert M. Bell and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Robert B. Stein

93 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

1992 1.6k citations Robert B. Stein et al. profile →
Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells.

1986 917 citations Robert B. Stein et al. profile →
Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions.

1994 545 citations Robert B. Stein, Donald P. McDonnell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert B. Stein United States	32	4.1k	2.3k	1.1k	1.0k	771	96	6.7k
Michael Karin United States	27	6.1k 1.5×	1.1k 0.5×	2.1k 2.0×	1.6k 1.5×	416 0.5×	35	9.5k
Jilly F. Evans United States	42	3.5k 0.9×	2.0k 0.8×	1.5k 1.5×	1.3k 1.2×	331 0.4×	105	9.9k
Johannes V. Swinnen Belgium	61	8.2k 2.0×	1.5k 0.6×	595 0.6×	1.3k 1.3×	670 0.9×	188	13.4k
Chieko Mineo United States	44	3.6k 0.9×	1.3k 0.5×	1.2k 1.1×	680 0.7×	623 0.8×	106	7.7k
Jean‐Claude Chambard France	34	4.6k 1.1×	972 0.4×	874 0.8×	1.2k 1.1×	521 0.7×	52	7.4k
Jerzy Ostrowski Poland	43	4.5k 1.1×	774 0.3×	529 0.5×	702 0.7×	368 0.5×	235	6.6k
Gerhard A. Coetzee United States	57	7.2k 1.8×	3.3k 1.4×	501 0.5×	1.6k 1.6×	430 0.6×	182	12.5k
Gail E. Sonenshein United States	62	6.7k 1.7×	1.0k 0.4×	2.3k 2.2×	2.8k 2.7×	409 0.5×	155	10.9k
Sotirios K. Karathanasis United States	42	3.1k 0.8×	1.1k 0.5×	565 0.5×	408 0.4×	639 0.8×	85	6.2k
Bruce Blumberg United States	20	4.1k 1.0×	3.5k 1.5×	737 0.7×	1.0k 1.0×	253 0.3×	36	7.6k

Countries citing papers authored by Robert B. Stein

Since Specialization

Citations

This map shows the geographic impact of Robert B. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Stein more than expected).

Fields of papers citing papers by Robert B. Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Stein. The network helps show where Robert B. Stein may publish in the future.

Co-authorship network of co-authors of Robert B. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Stein. A scholar is included among the top collaborators of Robert B. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Stein. Robert B. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mueller, Lauren, Roseanne S. Wexler, David A. Lovejoy, Robert B. Stein, & Andrew Slee. (2024). Teneurin C-terminal associated peptide (TCAP)-1 attenuates the development and expression of naloxone-precipitated morphine withdrawal in male Swiss Webster mice. Psychopharmacology. 241(8). 1565–1575. 1 indexed citations

Castle, John C., Mohamed Uduman, Simarjot Pabla, Robert B. Stein, & Jennifer S. Buell. (2019). Mutation-Derived Neoantigens for Cancer Immunotherapy. Frontiers in Immunology. 10. 1856–1856. 89 indexed citations

Waight, Jeremy D., Dhan Chand, Thomas Horn, et al.. (2018). Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens. Cancer Cell. 33(6). 1033–1047.e5. 64 indexed citations

Uduman, Mohamed, Kaity Tung, Bjarne Bogen, et al.. (2017). Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model. Blood. 130. 1868–1868. 3 indexed citations

Su, Chinyu, Bruce Salzberg, James D. Lewis, et al.. (2002). Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. The American Journal of Gastroenterology. 97(10). 2577–2584. 134 indexed citations

Stein, Robert B. & Gary R. Lichtenstein. (2001). Medical Therapy for Crohn's Disease. Surgical Clinics of North America. 81(1). 71–101. 29 indexed citations

Stein, Robert B., et al.. (2000). Pigtail stents: An alternative in the treatment of difficult bile duct stones. Gastrointestinal Endoscopy. 52(4). 490–493. 61 indexed citations

Su, Chinyu, Robert B. Stein, James D. Lewis, & Gary R. Lichtenstein. (2000). Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?. Digestive and Liver Disease. 32(6). 518–531. 26 indexed citations

Stein, Robert B., Gary R. Lichtenstein, & John L. Rombeau. (1999). Nutrition in inflammatory bowel disease. Current Opinion in Clinical Nutrition & Metabolic Care. 2(5). 367–371. 10 indexed citations

10.

Stein, Robert B. & S. B. Hanauer. (1998). Life-threatening complications of IBD: How to handle fulminant colitis and toxic megacolon: Clinical features, key diagnostic tests, and treatment options. 13(8). 518–525. 4 indexed citations

11.

Stein, Robert B. & Stephen B. Hanauer. (1998). Medical management of Crohn's disease. Drugs of today. 34(6). 541–541. 5 indexed citations

12.

Lamb, Peter, et al.. (1995). STAT protein complexes activated by interferon-γ and gp 130 signaling molecules differ in their sequence preferences and trascriptional induction properties. Nucleic Acids Research. 23(16). 3283–3289. 47 indexed citations

13.

McDonnell, Donald P., et al.. (1995). Cellular Mechanisms Which Distinguish between Hormone‐ and Antihormone‐Activated Estrogen Receptor. Annals of the New York Academy of Sciences. 761(1). 121–137. 43 indexed citations

14.

Lamb, Peter, Jonathan Haslam, Linda Kessler, et al.. (1994). Rapid Activation of the Interferon-γ Signal Transduction Pathway by Inhibitors of Tyrosine Phosphatases. Journal of Interferon Research. 14(6). 365–373. 22 indexed citations

15.

Riemen, Mark W., Ronald Wegrzyn, Audrey Baker, et al.. (1987). Isolation of multiple biologically and chemically diverse species of epidermal growth factor. Peptides. 8(5). 877–885. 15 indexed citations

16.

Delaume, Georges R., et al.. (1986). ILM volume 25 issue 6 Cover and Front matter. International Legal Materials. 25(6). f1–f14. 2 indexed citations

17.

Romano, A., et al.. (1980). Use of Human Fibroblast-Derived (Beta) Interferon in the Treatment of Epidemic Adenovirus Keratoconjunctivitis. Journal of Interferon Research. 1(1). 95–100. 20 indexed citations

18.

Delaume, Georges R., et al.. (1980). ILM volume 19 issue 1 Cover and Front matter. International Legal Materials. 19(1). f1–f10. 1 indexed citations

19.

Linshaw, Michael A., H. Harrison, Alan B. Gruskin, et al.. (1980). Hypochloremic alkalosis in infants associated with soy protein formula. The Journal of Pediatrics. 96(4). 635–640. 27 indexed citations

20.

Delaume, Georges R., et al.. (1978). ILM volume 17 issue 1 cover and front matter. International Legal Materials. 17(1). f1–f12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact